Addressing Regulatory Challenges in Clinical Trials of Cannabis-Related Drug Products

Read more

In this Journal for Clinical Studies article, Aman Khera, Barry J. Dussault, and Henry J. Riordan write about regulatory and operational considerations with the recent global interest in developing therapies related to cannabis.


VP, Regulatory Science, Strategy and Innovation

Want to learn more about Worldwide Clinical Trials?